Agilent Technologies Inc (A)vsDanaher Corporation (DHR)
A
Agilent Technologies Inc
$171.99
-1.65%
HEALTHCARE · Cap: $51.17B
DHR
Danaher Corporation
$230.08
+0.94%
HEALTHCARE · Cap: $163.25B
Smart Verdict
WallStSmart Research — data-driven comparison
Danaher Corporation generates 247% more annual revenue ($25.61B vs $7.37B). A leads profitability with a 19.5% profit margin vs 16.9%. DHR appears more attractively valued with a PEG of 1.32. DHR earns a higher WallStSmart Score of 65/100 (B-).
A
Buy63
out of 100
Grade: C+
DHR
Strong Buy65
out of 100
Grade: B-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-63.8%
Fair Value
$78.68
Current Price
$171.99
$93.31 premium
Intrinsic value data unavailable for DHR.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Large-cap with strong market position
Strong operational efficiency at 25.6%
Large-cap with strong market position
Strong operational efficiency at 21.1%
Earnings expanding 37.8% YoY
Generating 1.6B in free cash flow
Areas to Watch
Premium valuation, high expectations priced in
Grey zone — moderate risk
Weak financial health signals
Premium valuation, high expectations priced in
Comparative Analysis Report
WallStSmart ResearchBull Case : A
The strongest argument for A centers on Market Cap, Operating Margin. Profitability is solid with margins at 19.5% and operating margin at 25.6%. PEG of 1.47 suggests the stock is reasonably priced for its growth.
Bull Case : DHR
The strongest argument for DHR centers on Market Cap, Operating Margin, EPS Growth. Profitability is solid with margins at 16.9% and operating margin at 21.1%. PEG of 1.32 suggests the stock is reasonably priced for its growth.
Bear Case : A
The primary concerns for A are P/E Ratio, Altman Z-Score, Piotroski F-Score.
Bear Case : DHR
The primary concerns for DHR are P/E Ratio.
Key Dynamics to Monitor
A carries more volatility with a beta of 1.21 — expect wider price swings.
DHR is growing revenue faster at 8.3% — sustainability is the question.
DHR generates stronger free cash flow (1.6B), providing more financial flexibility.
Monitor DIAGNOSTICS & RESEARCH industry trends, competitive dynamics, and regulatory changes.
Bottom Line
DHR scores higher overall (65/100 vs 63/100), backed by strong 16.9% margins. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Agilent Technologies Inc
HEALTHCARE · DIAGNOSTICS & RESEARCH · USA
Agilent Technologies, Inc. is an American analytical instrumentation development and manufacturing company that offers its products and services to markets worldwide. Its global headquarters is located in Santa Clara, California.
Danaher Corporation
HEALTHCARE · DIAGNOSTICS & RESEARCH · USA
Danaher Corporation is an American globally diversified conglomerate with its headquarters in Washington, D.C.. The company designs, manufactures, and markets professional, medical, industrial, and commercial products and services. The company's 3 platforms are Life Sciences, Diagnostics, and Environmental & Applied Solutions.
Compare with Other DIAGNOSTICS & RESEARCH Stocks
Want to dig deeper into these stocks?